Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Giorgino G, Rosati D, Del Giudice F, Sciarra A, Mariotti G, Gentilucci A. Salciccia S, et al. Among authors: gentilucci a. Asian J Urol. 2024 Apr;11(2):191-207. doi: 10.1016/j.ajur.2023.01.002. Epub 2023 Feb 6. Asian J Urol. 2024. PMID: 38680577 Free PMC article. Review.
Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis.
Maggi M, Panebianco V, Mosca A, Salciccia S, Gentilucci A, Di Pierro G, Busetto GM, Barchetti G, Campa R, Sperduti I, Del Giudice F, Sciarra A. Maggi M, et al. Among authors: gentilucci a. Eur Urol Focus. 2020 May 15;6(3):463-478. doi: 10.1016/j.euf.2019.06.014. Epub 2019 Jul 4. Eur Urol Focus. 2020. PMID: 31279677
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.
Sciarra A, Gentilucci A, Cattarino S, Salsiccia S, Mariotti G. Sciarra A, et al. Among authors: gentilucci a. Minerva Urol Nephrol. 2021 Dec;73(6):863-865. doi: 10.23736/S2724-6051.21.04814-X. Minerva Urol Nephrol. 2021. PMID: 35144373 Free article. No abstract available.
Comment on: "Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile: an updated systematic review and meta-analysis".
Salciccia S, Sciarra A, Cattarino S, Mariotti G, Bevilacqua G, Gentilucci A. Salciccia S, et al. Among authors: gentilucci a. Minerva Urol Nephrol. 2022 Jun;74(3):360-362. doi: 10.23736/S2724-6051.22.04948-5. Minerva Urol Nephrol. 2022. PMID: 35607782 Free article. No abstract available.
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical Prostatectomy.
Salciccia S, Viscuso P, Bevilacqua G, Tufano A, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Gentilucci A, Lourdes Lia F, Ivan DG, Rosati D, Del Giudice F, Sciarra A, Mariotti G. Salciccia S, et al. Among authors: gentilucci a. Adv Urol. 2022 Jun 21;2022:8736249. doi: 10.1155/2022/8736249. eCollection 2022. Adv Urol. 2022. PMID: 35774194 Free PMC article. Review.
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Giorgino G, Rosati D, Del Giudice F, Sciarra A, Mariotti G, Gentilucci A. Salciccia S, et al. Among authors: gentilucci a. Int J Mol Sci. 2022 Sep 29;23(19):11501. doi: 10.3390/ijms231911501. Int J Mol Sci. 2022. PMID: 36232828 Free PMC article. Review.
Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer.
Salciccia S, Frisenda M, Bevilacqua G, Viscuso P, Casale P, De Berardinis E, Di Pierro GB, Cattarino S, Giorgino G, Rosati D, Del Giudice F, Carbone A, Pastore A, Chung BI, Eisenberg ML, Autorino R, Crivellaro S, Forte F, Sciarra A, Mariotti G, Gentilucci A. Salciccia S, et al. Among authors: gentilucci a. Curr Oncol. 2022 Dec 3;29(12):9474-9500. doi: 10.3390/curroncol29120745. Curr Oncol. 2022. PMID: 36547159 Free PMC article.
Inflammation and chronic prostatic diseases: evidence for a link?
Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Sciarra A, et al. Among authors: gentilucci a. Eur Urol. 2007 Oct;52(4):964-72. doi: 10.1016/j.eururo.2007.06.038. Epub 2007 Jul 2. Eur Urol. 2007. PMID: 17618043 Review.
69 results